Tricida EBIT

Tricida (TCDA) currently reports a EBIT of $-120M as of September 2022. That compares with $-110M in the prior-year period — down 15.9% year over year. That is below the Healthcare sector average of $22B. Use the charts on this page to explore Tricida's EBIT history and peer comparisons.

Tricida's EBIT decreased from $-110M to $-120M — a 15.9% year-over-year decrease (period ending September 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Tricida's EBIT of $-120M is lower than the Healthcare sector average of $22B. That is roughly 100.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Tricida reported $-120M in EBIT as of September 2022. That compares with $-110M in the prior-year period — down 15.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-120M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $22B. From there, open related valuation or income-statement pages for Tricida, and consider following TCDA for alerts when major investors trade the stock.